Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Restoration of defective cross-presentation in tumors by gemcitabine

McDonnell, A.M, Joost Lesterhuis, W., Khong, A., Nowak, A.K, Lake, R.A., Currie, A.J. and Robinson, B.W.S. (2015) Restoration of defective cross-presentation in tumors by gemcitabine. OncoImmunology, 4 (5).

PDF - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (130kB)
Free to read:
*No subscription required


Tumor antigen cross-presentation by dendritic cells (DCs) to specific CD8(+) T cells is central to antitumor immunity. Although highly efficient in draining lymph nodes, it is defective within the tumor site itself. Importantly, an immunogenic chemotherapy, gemcitabine, reverses this defect, allowing the potential re-stimulation of cytotoxic T lymphocytes within tumor sites.

Item Type: Journal Article
Murdoch Affiliation(s): School of Veterinary and Life Sciences
Publisher: Taylor & Francis
Copyright: © The Authors
Item Control Page Item Control Page


Downloads per month over past year